Novo Nordisk

Healthcare

Eli Lilly Upstages Novo Nordisk in Obesity Pill Face-Off

Photo via James Black/Icon Sportswire DHN/James Black/Icon Sportswire/Newscom

Both companies have been desperate to innovate beyond their current injectable GLP-1 weight-loss drugs for a while now.

1 min read

Photo by Robina Weermeijer via Unsplash

Healthcare

Lung Disease Breakthrough Boosts United Therapeutics — and its Rivals

About 5 million people are affected by idiopathic pulmonary fibrosis globally, according to the National Institutes of Health.

2 min read
Photo by jetcityimage via iStock

Healthcare

Eli Lilly Captures Major Lead in Weight-Loss Pill Race

Morgan Stanley analysts have estimated that Lilly’s GLP-1 pill could bring in as much as $40 billion in annual sales by 2033.

2 min read
Photo via Marcus Brandt/dpa/picture-alliance/Newscom

Healthcare

Novo Nordisk Soars After 50% Ozempic Discount, Liver Treatment Approval

Novo said cash-paying Americans can now buy Ozempic for $499 per month through various channels including its official website.

2 min read

Healthcare

Eli Lilly’s Miracle Weight Loss Pill May Not Be Miraculous Enough

Photo via Spencer Jones/GHI//UCG/Universal Images Group/Newscom

Lilly’s second-quarter results reported Thursday were still more than fine: $15.5 billion in revenue beat Wall Street estimates.

2 min read

Healthcare

Coming Soon to an Internet Near You: Half-Price, Direct-to-Consumer Wegovy

Photo via Novo Nordisk

Novo Nordisk will sell its blockbuster weight-loss drug Wegovy for under half its normal price via a new direct-to-consumer online pharmacy.

2 min read

Healthcare

AI Wants to be the Future of Drug Discovery

Photo by News Øresund – Kristoffer Dahl via CC BY 3.0

Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.